End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
14.2 CNY | +0.71% | +7.25% | -3.92% |
04-25 | Yifan Unit's Allergy Drug Passes China Regulatory Test, Stock Price Jumps | MT |
04-25 | Yifan Pharmaceutical's Unit Gets Nod to Register Nimodipine Injection | MT |
Business Summary
Number of employees: 4,230
Sales per Business
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical Product
76.2
%
| 3,353 | 87.4 % | 3,098 | 76.2 % | -7.60% |
Medicinal Raw Material and Polymer
23.8
%
| 484 | 12.6 % | 970 | 23.8 % | +100.49% |
Sales per region
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
70.2
%
| 2,721 | 70.9 % | 2,856 | 70.2 % | +4.96% |
Abroad
29.8
%
| 1,115 | 29.1 % | 1,212 | 29.8 % | +8.66% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Xian Feng Cheng
CHM | Chairman | 56 | 14/10/14 |
Guo Han Xu
CHM | Chairman | 57 | 30/09/14 |
De Qi Feng
BRD | Director/Board Member | 45 | 27/04/16 |
Xing Lin
BRD | Director/Board Member | 38 | 15/11/12 |
Ben Yu Zhou
BRD | Director/Board Member | 51 | 14/10/14 |
Lei Li
IRC | Investor Relations Contact | - | - |
Yan Bing Bai
PRN | Corporate Officer/Principal | 60 | 15/11/06 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Hongquan Liu
BRD | Director/Board Member | 65 | 26/11/20 |
Xian Feng Cheng
CHM | Chairman | 56 | 14/10/14 |
Ben Yu Zhou
BRD | Director/Board Member | 51 | 14/10/14 |
Lian Chun Zhang
BRD | Director/Board Member | 50 | - |
Yan Bing Bai
PRN | Corporate Officer/Principal | 60 | 15/11/06 |
Xin Tu Lei
BRD | Director/Board Member | 52 | 23/04/19 |
Xing Lin
BRD | Director/Board Member | 38 | 15/11/12 |
Guo Han Xu
CHM | Chairman | 57 | 30/09/14 |
Jun Wang
BRD | Director/Board Member | 52 | 29/03/18 |
Genhong Cheng
BRD | Director/Board Member | 61 | 23/04/19 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,226,024,827 | 647,578,569 ( 52.82 %) | 31,878,934 ( 2.600 %) | 52.82 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
BIOTON S.A. 31.72% | 27,235,211 | 31.72% | 24,382,050 $ |
Company contact information
Sector
Sales per Business
Sales per region
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-3.92% | 2.38B | |
+20.83% | 43.57B | |
+20.70% | 22.7B | |
+16.41% | 14.32B | |
+11.11% | 13.42B | |
+45.91% | 11.83B | |
-8.84% | 6.98B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+12.41% | 5.51B |
- Stock Market
- Equities
- 002019 Stock
- Company Yifan Pharmaceutical Co., Ltd.